The FDA has approved an oral liquid therapy for the treatment of central diabetes insipidus in people of all ages, according to a press release. Desmopressin acetate (Desmoda, Eton Pharmaceuticals) is ...

Clinicians now have an FDA-approved liquid desmopressin option for central diabetes insipidus, designed for dosing consistency across the age spectrum.

DESMODA is the first and only FDA-approved desmopressin oral solutionCommercial launch expected on March 9thDESMODA eliminates tablet splitting and crushing, enabling precise, individualized dosing ...

Diabetes insipidus is a rare condition that leads to excessive urination. This can lead to severe dehydration and high sodium levels — and these can mean serious complications. Share on Pinterest ...

Transient diabetes insipidus almost always begins within 24-48 h of surgery, and usually abates within several days. Both transient diabetes insipidus and the first phase of the triphasic pattern are ...

The study covered in this summary was published on Research Square as a preprint and has not yet been peer reviewed. The researchers suggest using as a cutoff a copeptin level of >3.4 pmol/L at ...

Mechanistically, thirst starts with the excitation of osmoregulatory cells in a brain structure called the lamina terminalis, which is located in the anterior wall of the third ventricle. The lamina ...

Please provide your email address to receive an email when new articles are posted on . A group of representatives from national and international endocrine, nephrology and pediatric societies has ...

Diabetes mellitus—known to many as type 1 and type 2 diabetes—gets all the attention with its rising global prevalence and connection to lifestyle and autoimmunity. Meanwhile, its lesser-known ...

The coronavirus disease 2019 (COVID-19) pandemic brought about by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has adversely impacted public health worldwide, leading to millions of ...

FDA authorized desmopressin acetate oral solution (Desmoda) for CDI/AVP-D across all ages, representing the first FDA-approved oral liquid desmopressin formulation in the United States.